Are you a researcher who has experience working with (or plans to work with) induced pluripotent stem (iPS) cells?  If so, we would like to hear from you.

SFARI has access to biospecimens suited for iPS cell generation from individuals with high-confidence autism risk variants (these individuals have participated in the Simons Simplex Collection and Simons VIP).  We are soliciting your feedback about the utility and priority of iPS cell models that you think will be most valuable for the autism research community.

Your comments will help us to create a research infrastructure that will allow the use of SFARI biospecimen resources in the most helpful and impactful way.

Click here to begin the survey.